Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?
Gespeichert in:
| Veröffentlicht in: | Drug discovery today 2004-10, Vol.9 (19), p.826-827 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 827 |
|---|---|
| container_issue | 19 |
| container_start_page | 826 |
| container_title | Drug discovery today |
| container_volume | 9 |
| creator | Wermuth, Camille G. |
| description | |
| doi_str_mv | 10.1016/S1359-6446(04)03213-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66899569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644604032131</els_id><sourcerecordid>66899569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-eb553f4a99a000a32f25a6223ff32f2634e1b261af12e0c27048ef5a34a625423</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EolD4BFBWCBYBj19N2FSo4iUVsQDWlpuMW6O0KXaC1F0_A36vX0LSFrFkNXdx7ozmEHIC9BIoqKsX4DKNlRDqnIoLyhnwGHbIASS9JJYJZ7tN_kU65DCEd0qBpVLtkw5IngBwdkCGT3VRucr4MVaYR7mvx-E6qiYY4SyPSruOq-VXOcN4Q8VtzF1AE3C1_I7mE1eUoZxPFv0jsmdNEfB4O7vk7e72dfAQD5_vHwc3wzjjCqoYR1JyK0yaGkqp4cwyaRRj3No2Ky4QRkyBscCQZqxHRYJWGi4aSgrGu-Rss3fuy48aQ6WnLmRYFGaGZR20UknaPJo2oNyAmS9D8Gj13Lup8QsNVLca9Vqjbh1pKvRao4amd7o9UI-mmP-1tt4aoL8BsHnz06HXIXM4yzB3HrNK56X758QPn6WCyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66899569</pqid></control><display><type>article</type><title>Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wermuth, Camille G.</creator><creatorcontrib>Wermuth, Camille G.</creatorcontrib><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/S1359-6446(04)03213-1</identifier><identifier>PMID: 15381132</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>AIDS tritherapy ; Animals ; Cytokine regulator ; Drug Therapy, Combination ; Humans ; Ligands ; Parkinson's disease ; Pharmaceutical Preparations - chemistry ; Pharmaceutical Preparations - metabolism ; Pharmacokinetics ; Pharmacology ; Pharmacophore</subject><ispartof>Drug discovery today, 2004-10, Vol.9 (19), p.826-827</ispartof><rights>2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-eb553f4a99a000a32f25a6223ff32f2634e1b261af12e0c27048ef5a34a625423</citedby><cites>FETCH-LOGICAL-c361t-eb553f4a99a000a32f25a6223ff32f2634e1b261af12e0c27048ef5a34a625423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1359644604032131$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15381132$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wermuth, Camille G.</creatorcontrib><title>Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><subject>AIDS tritherapy</subject><subject>Animals</subject><subject>Cytokine regulator</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Ligands</subject><subject>Parkinson's disease</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Pharmacokinetics</subject><subject>Pharmacology</subject><subject>Pharmacophore</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EolD4BFBWCBYBj19N2FSo4iUVsQDWlpuMW6O0KXaC1F0_A36vX0LSFrFkNXdx7ozmEHIC9BIoqKsX4DKNlRDqnIoLyhnwGHbIASS9JJYJZ7tN_kU65DCEd0qBpVLtkw5IngBwdkCGT3VRucr4MVaYR7mvx-E6qiYY4SyPSruOq-VXOcN4Q8VtzF1AE3C1_I7mE1eUoZxPFv0jsmdNEfB4O7vk7e72dfAQD5_vHwc3wzjjCqoYR1JyK0yaGkqp4cwyaRRj3No2Ky4QRkyBscCQZqxHRYJWGi4aSgrGu-Rss3fuy48aQ6WnLmRYFGaGZR20UknaPJo2oNyAmS9D8Gj13Lup8QsNVLca9Vqjbh1pKvRao4amd7o9UI-mmP-1tt4aoL8BsHnz06HXIXM4yzB3HrNK56X758QPn6WCyg</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>Wermuth, Camille G.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041001</creationdate><title>Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?</title><author>Wermuth, Camille G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-eb553f4a99a000a32f25a6223ff32f2634e1b261af12e0c27048ef5a34a625423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>AIDS tritherapy</topic><topic>Animals</topic><topic>Cytokine regulator</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Ligands</topic><topic>Parkinson's disease</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Pharmacokinetics</topic><topic>Pharmacology</topic><topic>Pharmacophore</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wermuth, Camille G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wermuth, Camille G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2004-10-01</date><risdate>2004</risdate><volume>9</volume><issue>19</issue><spage>826</spage><epage>827</epage><pages>826-827</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15381132</pmid><doi>10.1016/S1359-6446(04)03213-1</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1359-6446 |
| ispartof | Drug discovery today, 2004-10, Vol.9 (19), p.826-827 |
| issn | 1359-6446 1878-5832 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66899569 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | AIDS tritherapy Animals Cytokine regulator Drug Therapy, Combination Humans Ligands Parkinson's disease Pharmaceutical Preparations - chemistry Pharmaceutical Preparations - metabolism Pharmacokinetics Pharmacology Pharmacophore |
| title | Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A57%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multitargeted%20drugs:%20the%20end%20of%20the%20%E2%80%98one-target-one-disease%E2%80%99%20philosophy?&rft.jtitle=Drug%20discovery%20today&rft.au=Wermuth,%20Camille%20G.&rft.date=2004-10-01&rft.volume=9&rft.issue=19&rft.spage=826&rft.epage=827&rft.pages=826-827&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/S1359-6446(04)03213-1&rft_dat=%3Cproquest_cross%3E66899569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66899569&rft_id=info:pmid/15381132&rft_els_id=S1359644604032131&rfr_iscdi=true |